Benes, Jan
Kroupova, Katerina
Kotrc, Martin
Petrak, Jiri
Jarolim, Petr
Novosadova, Vendula
Kautzner, Josef
Melenovsky, Vojtech
Funding for this research was provided by:
Ministerstvo Zdravotnictví Ceské Republiky (NV19-02-00130)
Univerzita Karlova v Praze (UNCE/MED/016)
European Union- Next Generation EU (LX22NPO5104, LX22NPO5102)
Article History
Received: 3 April 2023
Accepted: 12 September 2023
First Online: 25 September 2023
Competing interests
: Josef Kautzner is a member of Advisory Boards for Boehringer Ingelheim, Biosense Webster, Medtronic and St Jude Medical (Abbott). He has received speaker honoraria from the above-mentioned companies and from Biotronik, Cath Vision, Pfizer and Pro Med CS. Petr Jarolim received research support from Abbott Laboratories, Amgen, Inc., AstraZeneca, LP, Daiichi-Sankyo, Inc., GlaxoSmithKline, Merck & Co., Inc., Regeneron, Roche Diagnostics Corporation, and Siemens Healthineers. Remaining authors do not possess Competing Interest.